Evidence map›Paper›PMID 28835688›Full record

ArticleScientific reports2017

The scaffold protein Ajuba suppresses CdGAP activity in epithelia to maintain stable cell-cell contacts.

J J McCormack, S Bruche, A B D Ouadda, H Ishii, H Lu, A Garcia-Cattaneo, C Chávez-Olórtegui, N Lamarche-Vane, V M M Braga

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. International journal of molecular sciences · 2025
    Article
  2. Article
  3. Fixing the GAP: The role of RhoGAPs in cancer.European journal of cell biology · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

J J McCormackMolecular Medicine, National Heart and Lung Institute, Imperial College London, SW7 2AZ, London, UK.
S BrucheMolecular Medicine, National Heart and Lung Institute, Imperial College London, SW7 2AZ, London, UK.
A B D OuaddaCancer Research Program, Research Institute-McGill University Hospital Centre and Department of Anatomy and Cell Biology, McGill University, H4A 3J1, Montreal, Quebec, Canada.
H IshiiCancer Research Program, Research Institute-McGill University Hospital Centre and Department of Anatomy and Cell Biology, McGill University, H4A 3J1, Montreal, Quebec, Canada.
H LuCancer Division, Faculty of Medicine, Imperial College London, SW7 2AZ, London, UK.
A Garcia-CattaneoMolecular Medicine, National Heart and Lung Institute, Imperial College London, SW7 2AZ, London, UK.
C Chávez-OlórteguiDepartment of Biochemistry and Immunology, Institute of Cell Biology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
N Lamarche-VaneCancer Research Program, Research Institute-McGill University Hospital Centre and Department of Anatomy and Cell Biology, McGill University, H4A 3J1, Montreal, Quebec, Canada.
V M M BragaMolecular Medicine, National Heart and Lung Institute, Imperial College London, SW7 2AZ, London, UK. v.braga@imperial.ac.uk.ORCID 0000-0003-0546-7163
Imperial College London · GBMcGill University Health Centre · CALung Institute · USUniversidade Federal de Minas Gerais · BR

Funding

Biotechnology and Biological Sciences Research Council BB/D526410/1CIHR MOP-119-544Medical Research Council MR/J007668/1Medical Research Council MR/M026310/1
6 · The paper itself

Abstract

Levels of active Rac1 at epithelial junctions are partially modulated via interaction with Ajuba, an actin binding and scaffolding protein. Here we demonstrate that Ajuba interacts with the Cdc42 GTPase activating protein CdGAP, a GAP for Rac1 and Cdc42, at cell-cell contacts. CdGAP recruitment to junctions does not require Ajuba; rather Ajuba seems to control CdGAP residence at sites of cell-cell adhesion. CdGAP expression potently perturbs junctions and Ajuba binding inhibits CdGAP activity. Ajuba interacts with Rac1 and CdGAP via distinct domains and can potentially bring them in close proximity at junctions to facilitate activity regulation. Functionally, CdGAP-Ajuba interaction maintains junctional integrity in homeostasis and diseases: (i) gain-of-function CdGAP mutants found in Adams-Oliver Syndrome patients strongly destabilize cell-cell contacts and (ii) CdGAP mRNA levels are inversely correlated with E-cadherin protein expression in different cancers. We present conceptual insights on how Ajuba can integrate CdGAP binding and inactivation with the spatio-temporal regulation of Rac1 activity at junctions. Ajuba provides a novel mechanism due to its ability to bind to CdGAP and Rac1 via distinct domains and influence the activation status of both proteins. This functional interplay may contribute towards conserving the epithelial tissue architecture at steady-state and in different pathologies.

Indexed as

Cell CommunicationAmino Acid SequenceAnimalsCell LineEpitheliumFluorescent Antibody TechniqueGTPase-Activating ProteinsHumansIntercellular JunctionsKeratinocytesLIM Domain ProteinsMiceModels, BiologicalProtein BindingProtein Interaction Domains and MotifsProtein TransportAJUBA protein, humanGTPase-Activating ProteinsLIM Domain Proteins

Identifiers

PMID28835688
PMCPMC5569031
OpenAlexW2749693052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.